Gene-editing treatment for sickle cell approved by FDA
Breakthrough treatments for sickle cell disease have been approved by the U.S. Food and Drug Administration (FDA).
Stay updated with breaking news from Genome Editing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Breakthrough treatments for sickle cell disease have been approved by the U.S. Food and Drug Administration (FDA).
Presenters at the American Society of Hematology Annual Meeting and Exposition agreed that novel strategies, such as CRISPR and base editing, have potential to fine-tune the latest immunotherapy advancements to increase the efficacy and durability of a range of treatments.
Ghana's National Biosafety Authority (NBA) has published its guidelines on Genome Editing and Gene Stacks with regards Genetically Modified...
Doha, Qatar:Sidra Medicine, a Qatar Foundation entity launched its Good Manufacturing Practice (GMP) facility yesterday, on the fourth and final day o...
The iterative random forest AI model helps unravel guide RNA molecular intricacies, forming a comprehensive knowledge base for CRISPR.